GlassScriptPhysician profile
Andrew Greenberg
NPI 1538322995
$7,941.68
in general payments reported to CMS, 2019-2025
29 companies · $1,376 in 2025
The $1,376 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,427 · 2020: $550 · 2021: $906 · 2022: $1,283 · 2023: $1,020 · 2024: $1,379 · 2025: $1,376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,759 · Entertainment: $16.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,759.22 |
| Entertainment | $16.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,145.96 | 2022-2025 | |
| Alcon Vision LLC | $905.40 | 2019-2025 | Clareon, Simbrinza, Eysuvis |
| Glaukos Corporation | $697.38 | 2019-2025 | Idosetr, Idose |
| New World Medical,INC. | $591.72 | 2019-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Clearpath |
| Oyster Point Pharma, INC. | $534.89 | 2022-2025 | Tyrvaya |
| Bausch & Lomb Americas INC. | $475.14 | 2022-2025 | Miebo, Xiidra, Envista Mx60 Iol |
| Aerie Pharmaceuticals, INC. | $474.10 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $438.39 | 2019-2025 | Cequa |
| Gotham Surgical Solutions & Devices, INC. | $385.00 | 2019 | |
| Allergan, INC. | $328.74 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $272.30 | 2021-2023 | |
| Tarsus Pharmaceuticals, INC. | $235.62 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $222.18 | 2019-2023 | |
| Genentech USA, INC. | $146.47 | 2023-2024 | Vabysmo |
| Johnson & Johnson Surgical Vision, INC. | $146.14 | 2021-2025 | Amo Phaco Needle, Tecnis Simplicity, Veritas Vision System |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $143.97 | 2020-2022 | |
| Thea Pharma INC. | $130.37 | 2022-2025 | Iyuzeh |
| Recordati_rare_diseases_inc. | $122.19 | 2024 | Cystadrops |
| Regeneron Healthcare Solutions, INC. | $121.83 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $117.04 | 2019-2021 | |
| Djo, LLC | $49.45 | 2022 | |
| Harrow Eye, LLC | $43.70 | 2024-2025 | Vevye |
| Mallinckrodt Hospital Products INC. | $41.44 | 2021 | |
| Kala Pharmaceuticals, INC. | $38.88 | 2021 | |
| Eyevance Pharmaceuticals LLC | $37.41 | 2022 | |
| Ocular Therapeutix, INC. | $33.11 | 2023-2024 | Dextenza |
| Ivantis, INC | $26.48 | 2020-2021 | |
| Rayner Intraocular Lenses Limited | $19.96 | 2025 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Optos, INC. | $16.42 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Greenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.